Literature DB >> 20628721

[Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances].

S Cohen1, K U Kühn, B Sträter, N Scherbaum, W Weig.   

Abstract

Unhindered sexuality plays an important role in the quality of life and this also holds true for patients with psychiatric illnesses. Knowledge concerning the complex neuronal and endocrine control mechanisms of sexual function reveals areas of possible dysfunction caused by the interactions between the control system, psychiatric drugs and addictive psychoactive substances. The differentiation of the cause of the dysfunction between being caused by the underlying illness and caused by other factors is difficult in practice. Both classical tri-cyclic antidepressants and selective serotonin uptake inhibitors can frequently cause adverse effects in multiple dimensions of sexual function. This same is true for neuroleptics, whereby the differentiation between symptoms of schizophrenia and side-effects from the medication can make an evaluation difficult. The medication-based strategy used to treat opiate dependency by administration of methadone causes sexual dysfunction in many cases. The consideration of medication-induced sexual dysfunction has a great importance with regard to compliance. Possible solutions can be modification of the medication regime, additional medication, e.g. partial antagonists and PD5 inhibitors, as well as dysfunction-specific psychotherapy and psychoeducation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628721     DOI: 10.1007/s00115-010-3074-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  41 in total

1.  Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.

Authors:  M Hummer; G Kemmler; M Kurz; I Kurzthaler; H Oberbauer; W W Fleischhacker
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

2.  Naltrexone-induced augmentation of sexual response in men.

Authors:  R S Sathe; B R Komisaruk; A K Ladas; S V Godbole
Journal:  Arch Med Res       Date:  2001 May-Jun       Impact factor: 2.235

3.  Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.

Authors:  A L Montejo; G Llorca; J A Izquierdo; F Rico-Villademoros
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

4.  Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients.

Authors:  István Bitter; Bruce R Basson; Martin R Dossenbach
Journal:  Int Clin Psychopharmacol       Date:  2005-01       Impact factor: 1.659

5.  Plasma testosterone levels in heroin addiction and during methadone maintenance.

Authors:  J H Mendelson; J E Mendelson; V D Patch
Journal:  J Pharmacol Exp Ther       Date:  1975-01       Impact factor: 4.030

6.  Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects.

Authors:  Gavin Bart; Lisa Borg; James H Schluger; Mark Green; Ann Ho; Mary Jeanne Kreek
Journal:  J Pharmacol Exp Ther       Date:  2003-05-02       Impact factor: 4.030

7.  Sexual dysfunction in male schizophrenic patients.

Authors:  D Aizenberg; Z Zemishlany; P Dorfman-Etrog; A Weizman
Journal:  J Clin Psychiatry       Date:  1995-04       Impact factor: 4.384

8.  The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France.

Authors:  Mireille Bonierbale; Christophe Lançon; Jean Tignol
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

Review 9.  Sexual dysfunction and antipsychotic treatment.

Authors:  A J Cutler
Journal:  Psychoneuroendocrinology       Date:  2003-01       Impact factor: 4.905

10.  Naltrexone in the treatment of adolescent sexual offenders.

Authors:  Ralph S Ryback
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

View more
  4 in total

1.  Antidepressant adherence: are patients taking their medications?

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2012-05

Review 2.  Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma.

Authors:  Narayan D Chaurasiya; Francisco Leon; Ilias Muhammad; Babu L Tekwani
Journal:  Molecules       Date:  2022-07-04       Impact factor: 4.927

3.  Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study.

Authors:  Cicek Hocaoglu; Fatmagul H Celik; Gokhan Kandemir; Hulya Guveli; Bulent Bahceci
Journal:  Shanghai Arch Psychiatry       Date:  2014-12

Review 4.  Lifestyles and sexuality in men and women: the gender perspective in sexual medicine.

Authors:  Daniele Mollaioli; Giacomo Ciocca; Erika Limoncin; Stefania Di Sante; Giovanni Luca Gravina; Eleonora Carosa; Andrea Lenzi; Emmanuele Angelo Francesco Jannini
Journal:  Reprod Biol Endocrinol       Date:  2020-02-17       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.